港交所(00388.HK)委任三董事於AGM上通過 張懿宸反對票達23%
港交所(00388.HK)公布,其昨日(28日)舉行之股東周年大會上所有決議案均獲得通過,繼政府委任梁(穎)宇及再度委任席伯倫及姚建華,及股東選任聶雅倫、張明明及張懿宸為香港交易所董事後,交易所及其主要附屬公司的委員會或諮詢小組已委任新成員,有關委任即時生效。各董事於委員會或諮詢小組的任期與其香港交易所董事服務任期相同。
根據股東周年大會投票表決結果,選任聶雅倫及張明明為董事之議案分別獲98.92%及99.87%贊成,惟選任張懿宸為董事之議案則僅得76.98%贊成,有23.02%反對。傳媒報道指,早前獨立投票顧問Glass Lewis指出,張懿宸現時身兼多間公司董事,未必有足夠時間履行港交所董事職務,建議港交所股東對他出任獨董的議案投下反對票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.